Topiroxostat is an active pharmaceutical ingredient that functions as a xanthine oxidase inhibitor, used in the manufacturing of medications for conditions related to elevated uric acid levels. It was approved for pharmaceutical use in Japan in 2013.
Content scope: Information here supports chemical identification and industrial supply, research, and manufacturing contexts. It is not a therapeutic claim, medical advice, or drug-use instructions.
Sourcing Topiroxostat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.
Tigulixostat
pharmaceutical raw material
Oxypurinol
pharmaceutical raw material
Montelukast Dicyclohexylamine Salt
pharmaceutical raw material
Closantel
pharmaceutical raw material
Domperidone
pharmaceutical raw material
Idarubicin hydrochloride
pharmaceutical raw material
The international HS code for Topiroxostat (CAS 577778-58-6) is 2933.39.
2933.39
2933 39 99
Classification per the EU customs inventory ECICS (2026-07 snapshot, HS 2022). National tariff lines and product form can affect the final classification.
4-(5-pyridin-4-yl-1H-1,2,4-triazol-3-yl)pyridine-2-carbonitrile
UBVZQGOVTLIHLH-UHFFFAOYSA-N
C1=CN=CC=C1C2=NC(=NN2)C3=CC(=NC=C3)C#N
Sourcing Topiroxostat?
Post a free purchase request — no account needed. It reaches suppliers of this product, and replies go straight to your inbox.